May 16, 2017
From the Healthcare & Life Sciences Institute
Effective cybersecurity, privacy, and risk management are top priorities for medical device manufacturers (MDMs) and providers. However, some have struggled with where to start and to what extent to commit their finite resources. The Food and Drug Administration (FDA) is expected to help with that effort in the near future by progressing from pre- and post-market recommendations based on industry standards to specific directives and requirements that companies must follow.